XML 23 R8.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Operating Activities      
Net income $ 3,333,751 $ 1,579,776 $ 356,711
Adjustments to reconcile net income to net cash provided by operating activities:      
Amortization, depreciation and write-offs 194,778 448,680 489,008
Goodwill impairment 188,943 0 0
Stock-based compensation, excluding cash-settled awards 210,421 369,367 363,107
Gain on divestiture, net of transaction costs (106,229) 0 0
Impairment of investments 50,000 0 27,953
Loss on settlement of debt 0 28,375 4,337
Change in operating right-of-use assets 12,295 12,689 17,842
Other 9,213 9,663 11,226
Changes in operating assets and liabilities:      
Accounts receivable (542,219) (467,028) (261,279)
Prepaid expenses and other assets 134,658 (185,331) (133,968)
Accounts payable 232,486 189,585 98,574
Operating lease liabilities (15,229) (14,106) (18,612)
Accrued and other liabilities 268,226 127,341 106,611
Net cash provided by operating activities 3,971,094 2,099,011 1,061,510
Investing Activities      
Purchase of intangible assets (28,318) (25,553) (63,899)
Purchase of non-marketable equity securities (20,178) (76,983) (17,934)
Proceeds from divestiture, net of cash divested 407,297 0 0
Other investing activities (373) (4,218) 4,004
Net cash provided by (used in) investing activities 358,428 (106,754) (77,829)
Financing Activities      
Repurchases of common stock (2,191,944) (981,297) (1,153,593)
Payments of withholding taxes related to net share settlement (392,410) (1,143,525) (246,435)
Principal repayments of debt (200,000) (4,225,223) (497,994)
Payments of deferred acquisition costs 0 0 (33,903)
Principal payments of finance leases (18,669) (20,875) (20,170)
Payments of licensed asset obligation (13,532) 0 (27,110)
Payments of debt issuance cost (1,843) (35,563) (4,655)
Proceeds from issuance of debt 200,000 4,614,841 395,281
Proceeds from issuance of common stock upon exercise of stock options and purchase of ESPP shares 25,329 41,798 25,788
Net cash used in financing activities (2,593,069) (1,749,844) (1,562,791)
Effect of foreign exchange rate on cash and cash equivalents 9,232 (3,154) 778
Net increase in cash and cash equivalents, including cash classified within current assets of discontinued operations 1,745,685 239,259 (578,332)
Less: net decrease in cash classified within current assets of discontinued operations (44,381) 0 0
Net (decrease) increase in cash and cash equivalents 1,790,066 239,259 (578,332)
Cash and cash equivalents at beginning of the period 697,030 502,152 1,080,484
Cash and cash equivalents at end of the period 2,487,096 697,030 502,152
Cash and cash equivalents at end of the period   741,411 502,152
Supplemental non-cash investing and financing activities disclosures:      
Non-cash consideration received from divestiture 285,000 0 0
Right-of-use assets obtained in exchange for lease obligations, net of modifications (28,570) 26,325 119,911
Accrued withholding taxes related to net share settlement of restricted stock units 0 8,606 0
Supplemental disclosure of cash flow information:      
Cash paid for income taxes, net of refunds 194,843 67,332 75,433
Cash paid for interest $ 198,788 $ 270,615 $ 248,828